Ono Pharmaceutical Co. Ltd: Neoplasms trials

The registry lists 10 Neoplasms studies with Ono Pharmaceutical Co. Ltd as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 9Phase 2 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid TumorsTerminatedNCT03717415Phase 1/2Results posted
• A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid TumorsTerminatedNCT03601897Phase 1/2Results posted
• ONO-4538 Phase I Study in Patients With Solid TumorCompletedNCT02261285Phase 1Results posted
• ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in JapanCompletedNCT00836888Phase 1Results posted
• Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid TumorsTerminatedNCT06535009Phase 1
• Phase 1 Study of ONO-7475 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid TumorsCompletedNCT03730337Phase 1
• Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid TumorsTerminatedNCT03182257Phase 1
• ONO-4538 Phase I Study in Patients With Solid TumorCompletedNCT02261298Phase 1
• A Study of DCC-2701 in Participants With Advanced Solid TumorsTerminatedNCT02228811Phase 1
• ONO-7436 Phase II Study in JapanCompletedNCT00212602Phase 2